Literature DB >> 9356092

Long Q-T syndrome associated with oral erythromycin used in preoperative bowel preparation.

A W Vogt1, R A Zollo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9356092     DOI： 10.1097/00000539-199711000-00010

Source DB:  PubMed          Journal:  Anesth Analg        ISSN： 0003-2999            Impact factor:   5.108


× No keyword cloud information.
  8 in total

1.  Azithromycin and the risk of cardiovascular death.

Authors:  Wayne A Ray; Katherine T Murray; Kathi Hall; Patrick G Arbogast; C Michael Stein
Journal:  N Engl J Med       Date:  2012-05-17       Impact factor: 91.245

2.  Use of azithromycin and risk of ventricular arrhythmia.

Authors:  Gianluca Trifirò; Maria de Ridder; Janet Sultana; Alessandro Oteri; Peter Rijnbeek; Serena Pecchioli; Giampiero Mazzaglia; Irene Bezemer; Edeltraut Garbe; Tania Schink; Elisabetta Poluzzi; Trine Frøslev; Mariam Molokhia; Igor Diemberger; Miriam C J M Sturkenboom
Journal:  CMAJ       Date:  2017-04-18       Impact factor: 8.262

Review 3.  Macrolide antibiotics and the risk of cardiac arrhythmias.

Authors:  Richard K Albert; Joseph L Schuller
Journal:  Am J Respir Crit Care Med       Date:  2014-05-15       Impact factor: 21.405

4.  Estimated Cardiac Risk Associated With Macrolides and Fluoroquinolones Decreases Substantially When Adjusting for Patient Characteristics and Comorbidities.

Authors:  Linnea A Polgreen; Benjamin N Riedle; Joseph E Cavanaugh; Saket Girotra; Barry London; Mary C Schroeder; Philip M Polgreen
Journal:  J Am Heart Assoc       Date:  2018-04-21       Impact factor: 5.501

5.  Association of Azithromycin Use With Cardiovascular Mortality.

Authors:  Jonathan G Zaroff; T Craig Cheetham; Niki Palmetto; Lucy Almers; Charles Quesenberry; Jennifer Schneider; Nicolle Gatto; Douglas A Corley
Journal:  JAMA Netw Open       Date:  2020-06-01

Review 6.  A short focus, azithromycin in the treatment of respiratory viral infection COVID-19: efficacy or inefficacy?

Authors:  Antonio Vitiello; Francesco Ferrara
Journal:  Immunol Res       Date:  2021-11-05       Impact factor: 2.829

7.  Erythromycin, QTc interval prolongation, and torsade de pointes: Case reports, major risk factors and illness severity.

Authors:  Jules C Hancox; Mehrul Hasnain; W Victor R Vieweg; Michael Gysel; Michelle Methot; Adrian Baranchuk
Journal:  Ther Adv Infect Dis       Date:  2014-04

Review 8.  Azithromycin in COVID-19 Patients: Pharmacological Mechanism, Clinical Evidence and Prescribing Guidelines.

Authors:  Janet Sultana; Paola Maria Cutroneo; Salvatore Crisafulli; Gabriele Puglisi; Gaetano Caramori; Gianluca Trifirò
Journal:  Drug Saf       Date:  2020-08       Impact factor: 5.606
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.